|
|
 | | | |
- close
- close
- close
- close
Forbes
Dec 9
Comment
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one
StreetInsider.com
Nov 15
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Cubist+%28CBST%29%2C+Adolor+%28ADLR%29+Pass+HSR+Act+Waiting+Period/6950156.html for the full story.
Nov 12
Comment
On 10/24/2011 Cubist (click for archive of my blog posts re CBST) announced a buyout of Adolor(click for research page)
This deal surprised many people, but in hindsight it fits with the sort of assets that CBST has stated a desire to...
Benzinga
Oct 31
Comment
Earlier this week, Cubist Pharmaceuticals announced that they would acquire Adolor Corp for $4.25/share. The deal carried an interested provision, in which Adolor's shareholders who tendered their shares could receive a Contingent Payment Right...
Strategic Stocks and Penny Stocks
Oct 25
Comment
Stocks To Watch ADOLOR CORPORATION (NASDAQ: ADLR)
Up 143.23% on Monday
Adolor Corporation (ADLR) is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain and pain management...
Strategic Stocks and Penny Stocks
Oct 25
Comment
Stocks To Watch KATY, ADLR, SDRG, ECDC, TUCN, UNVC
For Tuesday, October 25th:
KATY, ADLR, SDRG, ECDC, TUCN, UNVC
[caption id="attachment_714" align="alignright" width="300" caption="Stocks To Watch KATY, ADLR, SDRG, ECDC, TUCN,...
Marketwire
Oct 25
Comment
HONG KONG -- (Marketwire) -- 10/25/11 -- Today, www.WorldStreetFundamentals.com released its industry report highlighting Cray Inc. (NASDAQ: CRAY) and Adolor Corporation (NASDAQ: ADLR). Full fundamental and technical analysis is available at
StreetInsider.com
Oct 24
Comment
Adolor Corporation (NASDAQ: ADLR) 129% HIGHER; agreed to be acquired by Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) for $4.25 per share in cash, or approximately $190 million on a fully-diluted basis.
Healthspring (NYSE: HS) 33.3% HIGHER; CIGNA...
FierceBiotech
Oct 24
Comment
With its share price breaking through to a 52-week high, Cubist Pharmaceuticals ($CBST) has decided to beef up its pipeline of acute care products with a deal to buy Adolor Pharmaceuticals for $190 million in cash and even more than that in...
StreetInsider.com
Aug 10
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Adolor+%28ADLR%29+Reports+Statistically+Significant+Results+from+ADL5945+Phase+2/6702688.html for the full story.
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS|
Error creating thumbnail: convert: unable to open image `/home/wikinvest/src_live_2/mediawiki/images/9/98/New_stock.png': No such file or directory @ blob.c/OpenBlob/2480. convert: unable to open file `/home/wikinvest/src_live_2/mediawiki/images/9/98/New_stock.png' @ png.c/ReadPNGImage/2889. convert: missing an image filename `/home/wikinvest/src_live_2/mediawiki/images/thumb/9/98/New_stock.png/35px-New_stock.png' @ convert.c/ConvertImageCommand/2800. |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
